Integra LifeSciences Holdings Co (NASDAQ: IART) suffers from meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly.
Recent notable negative changes in investment behavior have affected Integra LifeSciences Holdings Co (NASDAQ: IART): its shorter term price trend turned down.
In light of these highly negative signals we are reviewing our current Overall Rating of D. We would continue to view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Integra LifeSciences Holdings has a slightly positive Appreciation Score of 69 but a very low Power Rating of 2, and the Negative Value Trend Rating results.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock suffered a large decline of -7.1% on 8/5/24. The stock closed at $22.34. Trading volume in this decline was normal. The stock has declined -28.9% during the last week and has been extremely weak relative to the market over the last nine months.
Be the first to comment